SCHEMBL8537019

SCHEMBL8537019

Nc1ccc(Cl)cc1-c1ncc[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 6/20 0.57
NR4A2 P43354 2/20 0.42
SOS2 Q07890 1/20 0.42
CYP3A4 P08684 2/20 0.41
TSHR P16473 2/20 0.41
ALDH1A1 P00352 1/20 0.41
ALOX15 P16050 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
DYRK1B Q9Y463 2/20 0.41
CSNK1A1 P48729 1/20 0.41
TYRO3 Q06418 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
DYRK3 O43781 1/20 0.39
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
CDK5 Q00535 1/20 0.39
DYRK1A Q13627 1/20 0.39
CDK5R1 Q15078 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8537063 0.88 NR4A2 (0.43) IDO1NR4A2SOS2CYP3A4TSHR
SCHEMBL31429694 0.82 IDO1 (0.51) IDO1CYP3A4TSHRALDH1A1TDP1
SCHEMBL32667989 0.82 CSNK1A1 (0.42) IDO1CYP3A4TSHRALDH1A1SMN1; SMN2
SCHEMBL8542466 0.82 ALDH1A1 (0.49) IDO1CYP3A4ALDH1A1DYRK1BCSNK1A1
SCHEMBL29084865 0.81 IDO1 (0.58) IDO1TSHRALDH1A1ALOX15SMN1; SMN2
SCHEMBL31429733 0.81 IDO1 (0.58) IDO1TSHRALDH1A1ALOX15SMN1; SMN2
SCHEMBL3631532 0.80 RAB9A (0.50) ALDH1A1SMN1; SMN2DYRK1BCSNK1A1TYRO3
SCHEMBL31658923 0.79 IDO1 (0.57) IDO1ALDH1A1DYRK1BCSNK1A1TYRO3
SCHEMBL8558526 0.79 NPC1 (0.40) IDO1NR4A2CYP3A4ALDH1A1DYRK1B
SCHEMBL8541383 0.77 KMO (0.43) IDO1CYP3A4ALDH1A1DYRK1BCSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0857171-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1998-08-12 EP disclosed
WO-1997015555-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1997-05-01 WO disclosed